Value through Innovation17 January 2013

Diabetes News and Information

This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Diabetes Press Releases

back 1 2 3 4 5 6 7 8 next

02.10.2012	Analyses presented at EASD support Trajenta® (linagliptin) as effective and well-tolerated for patients with type 2 diabetes with different background therapies - EX US & UK. Medical Media Only.
02.10.2012	Clinical data for investigational SGLT2 inhibitor, empagliflozin*, demonstrates potential for oral treatment in type 2 diabetes - EX US & UK. Medical Media Only.
24.09.2012	New data from Boehringer Ingelheim and Lilly showcase strength of Diabetes Alliance at EASD Annual Meeting - EX US & UK Medical Media Only
21.09.2012	CHMP recommends indication for the use of Trajenta® (linagliptin) tablets as add-on therapy to insulin in adults with Type 2 Diabetes in Europe - For Non-U.S. and Non-UK Media
25.07.2012	Jentadueto® (linagliptin/metformin hydrochloride) tablets receive approval for the treatment of adults with Type 2 Diabetes in Europe - For Non-U.S. and Non-UK Media

back 1 2 3 4 5 6 7 8 next

Further Press Releases in our Archive

Diabetes Related News Room

Resources
Videos

Diabetes Related Documents

Diabetes Video Gallery

Mode of Action of DPP-4 Inhibitors
- Watch the Video
Diabetes Complications Animation
- Watch the video
Professor Anthony Barnett: Advantages of DPP-4 inhibitors in the treatment of type 2 diabetes
- Watch the Video(WMV)
Professor Anthony Barnett: Renal impairment in type 2 diabetes
- Watch the video(WMV)
Professor Anthony Barnett: The potential of linagliptin
- Watch the video(WMV)